
Benzinga Pro data, AnaptysBio (NASDAQ:ANAB) reported Q1 sales of $970.00 thousand. Earnings fell to a loss of $36.26 million, resulting in a 11.42% decrease from last quarter. In Q4, AnaptysBio brought in $1.01 million in sales but lost $32.54 million in earnings.